AdventHealth Hematology and Oncology — Orlando, Florida

AdventHealth Hematology and Oncology is a clinical research site located in Orlando, Florida, United States 32804.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

AdventHealth Hematology and Oncology has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Carcinoma, Small Cell Lung.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, EpicentRx, Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AdventHealth Hematology and Oncology?

AdventHealth Hematology and Oncology has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AdventHealth Hematology and Oncology conducted?

AdventHealth Hematology and Oncology has 6 clinical trials on record, with 5 currently active. Their work covers HER2-positive Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Carcinoma, Small Cell Lung.

Is AdventHealth Hematology and Oncology accredited by Crixeo Health?

AdventHealth Hematology and Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AdventHealth Hematology and Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.